{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:55:08Z","timestamp":1791564908149,"version":"4.3.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017959","name":"Health Commission of Hebei Province","doi-asserted-by":"publisher","award":["20260047"],"award-info":[{"award-number":["20260047"]}],"id":[{"id":"10.13039\/100017959","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejphar.2026.179309","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:38:56Z","timestamp":1788417536000},"page":"179309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Dapagliflozin ameliorates pulmonary arterial hypertension-induced right heart failure via ketone body metabolism and mitochondrial function enhancement"],"prefix":"10.1016","volume":"1034","author":[{"given":"Wendong","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longlong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Er","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuwei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongpin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejphar.2026.179309_bib1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41392-025-02287-8","article-title":"Signaling pathways and targeted therapy for pulmonary hypertension","volume":"10","author":"Adu-Amankwaah","year":"2025","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"10.1016\/j.ejphar.2026.179309_bib2","article-title":"Pulmonary arterial hypertension: Recognition and management in primary and acute care settings","volume":"17","author":"Ahern","year":"2025","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.ejphar.2026.179309_bib3","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1164\/rccm.202110-2274OC","article-title":"Macrophage-NLRP3 activation promotes right ventricle failure in pulmonary arterial hypertension","volume":"206","author":"Al-Qazazi","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179309_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12933-019-0980-4","article-title":"Sodium-glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy","volume":"19","author":"Arow","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ejphar.2026.179309_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2026.119012","article-title":"Hydrogen sulphide as a potential contributer to cardiovascular protection with sodium-glucose cotransporter 2 inhibition","volume":"195","author":"Berenyiova","year":"2026","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"10.1016\/j.ejphar.2026.179309_bib6","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.21037\/jtd-23-906","article-title":"Analysis of the role of glucose metabolism-related genes in dilated cardiomyopathy based on bioinformatics","volume":"15","author":"Chen","year":"2023","journal-title":"J. Thorac. Dis."},{"issue":"10","key":"10.1016\/j.ejphar.2026.179309_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13102422","article-title":"Head-to-Head in heart failure: comparative insights on empagliflozin and dapagliflozin","volume":"13","author":"Cozma","year":"2025","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179309_bib8","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/ehf2.14169","article-title":"Dapagliflozin reduces pulmonary vascular damage and susceptibility to atrial fibrillation in right heart disease","volume":"10","author":"Dai","year":"2023","journal-title":"ESC Heart Fail."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179309_bib9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11886-024-02157-9","article-title":"Novel therapies for right ventricular failure","volume":"27","author":"Das","year":"2025","journal-title":"Curr. Cardiol. Rep."},{"issue":"7","key":"10.1016\/j.ejphar.2026.179309_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/metabo12070635","article-title":"Exercise augments the effect of SGLT2 inhibitor dapagliflozin on experimentally induced diabetic cardiomyopathy, possible underlying mechanisms","volume":"12","author":"Eldesoqui","year":"2022","journal-title":"Metabolites"},{"issue":"4","key":"10.1016\/j.ejphar.2026.179309_bib11","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/ki.2013.451","article-title":"Sodium-glucose linked transporter-2 inhibitors: potential for renoprotection beyond blood glucose lowering?","volume":"86","author":"Gilbert","year":"2014","journal-title":"Kidney Int."},{"issue":"35","key":"10.1016\/j.ejphar.2026.179309_bib12","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1093\/eurheartj\/ehab364","article-title":"2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy","volume":"42","author":"Glikson","year":"2021","journal-title":"Eur. Heart J."},{"issue":"5","key":"10.1016\/j.ejphar.2026.179309_bib13","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1093\/nar\/gkad1193","article-title":"Histone lactylation-boosted ALKBH3 potentiates tumor progression and diminished promyelocytic leukemia protein nuclear condensates by m1A demethylation of SP100A","volume":"52","author":"Gu","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179309_bib14","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12889-025-24972-7","article-title":"Global disease burden of pulmonary arterial hypertension: patterns and inequality in 1990-2021, with projections to 2035","volume":"26","author":"Guan","year":"2026","journal-title":"BMC Public Health"},{"issue":"4","key":"10.1016\/j.ejphar.2026.179309_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2021.100857","article-title":"A simplified diagnostic and therapeutic approach to pulmonary hypertension","volume":"47","author":"Gupta","year":"2022","journal-title":"Curr. Probl. Cardiol."},{"issue":"3","key":"10.1016\/j.ejphar.2026.179309_bib16","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00395-025-01103-2","article-title":"The ketone body 3-hydroxybutyrate increases cardiac output and cardiac contractility in a porcine model of cardiogenic shock: a randomized, blinded, crossover trial","volume":"120","author":"H\u00f8rsdal","year":"2025","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.ejphar.2026.179309_bib17","doi-asserted-by":"crossref","DOI":"10.1097\/FJC.0000000000001795","article-title":"Dapagliflozin reduces myocardial injuries through modulation of H3K27me3 and SIRT1 in the male rat model of myocardial ischemia reperfusion","author":"Kianfar","year":"2026","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejphar.2026.179309_bib18","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01324-2024","article-title":"Definition, classification and diagnosis of pulmonary hypertension","volume":"64","author":"Kovacs","year":"2024","journal-title":"Eur. Respir. J."},{"issue":"16","key":"10.1016\/j.ejphar.2026.179309_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23169133","article-title":"Renin as a marker of tissue perfusion, septic shock and mortality in septic patients: a prospective observational study","volume":"23","author":"Le\u015bnik","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179309_bib20","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3892\/etm.2021.10147","article-title":"SGLT2 promotes cardiac fibrosis following myocardial infarction and is regulated by miR-141","volume":"22","author":"Li","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ejphar.2026.179309_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176875","article-title":"Dapagliflozin alleviates right heart failure by promoting collagen degradation by reducing ROS levels","volume":"981","author":"Liu","year":"2024","journal-title":"Eur. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.ejphar.2026.179309_bib22","article-title":"Ketone metabolism in the failing heart","volume":"1865","author":"Lopaschuk","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"issue":"12","key":"10.1016\/j.ejphar.2026.179309_bib23","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.medcli.2022.01.003","article-title":"Pulmonary arterial hypertension","volume":"158","author":"Luna-L\u00f3pez","year":"2022","journal-title":"Med. Clin."},{"key":"10.1016\/j.ejphar.2026.179309_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2024.07.030","article-title":"Pulmonary hypertension associated to left heart disease: phenotypes and treatment","volume":"129","author":"Madonna","year":"2024","journal-title":"Eur. J. Intern. Med."},{"issue":"5","key":"10.1016\/j.ejphar.2026.179309_bib25","doi-asserted-by":"crossref","DOI":"10.1111\/eci.14386","article-title":"Sotatercept in pulmonary hypertension and beyond","volume":"55","author":"Madonna","year":"2025","journal-title":"Eur. J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.ejphar.2026.179309_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/eci.70038","article-title":"Pulmonary hypertension and associated heart failure: new insights on emerging signalling pathways","volume":"55","author":"Madonna","year":"2025","journal-title":"Eur. J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.ejphar.2026.179309_bib27","doi-asserted-by":"crossref","first-page":"C1416","DOI":"10.1152\/ajpcell.00241.2024","article-title":"Emerging roles of ketone bodies in cardiac fibrosis","volume":"327","author":"Maduray","year":"2024","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"7","key":"10.1016\/j.ejphar.2026.179309_bib28","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1161\/CIRCRESAHA.123.321872","article-title":"Ketones and the heart: metabolic principles and therapeutic implications","volume":"132","author":"Matsuura","year":"2023","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179309_bib29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11897-023-00589-y","article-title":"Myocardial metabolism in heart failure","volume":"20","author":"Ng","year":"2023","journal-title":"Curr. Heart Fail. Rep."},{"issue":"4","key":"10.1016\/j.ejphar.2026.179309_bib30","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jjcc.2021.05.003","article-title":"Potential pitfalls when interpreting plasma BNP levels in heart failure practice","volume":"78","author":"Nishikimi","year":"2021","journal-title":"J. Cardiol."},{"key":"10.1016\/j.ejphar.2026.179309_bib31","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pupt.2015.09.007","article-title":"Exploring the monocrotaline animal model for the study of pulmonary arterial hypertension: a network approach","volume":"35","author":"Nogueira-Ferreira","year":"2015","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.ejphar.2026.179309_bib32","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/sj.bjp.0706381","article-title":"Effects of combined inhibition of the Na+-H+ exchanger and angiotensin-converting enzyme in rats with congestive heart failure after myocardial infarction","volume":"146","author":"Ruetten","year":"2005","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.ejphar.2026.179309_bib33","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.1002\/ehf2.13634","article-title":"Chronic exogenous ketone supplementation blunts the decline of cardiac function in the failing heart","volume":"8","author":"Takahara","year":"2021","journal-title":"ESC Heart Fail."},{"issue":"12","key":"10.1016\/j.ejphar.2026.179309_bib34","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004417","article-title":"Cardiac-specific Bdh1 overexpression ameliorates oxidative stress and cardiac remodeling in pressure overload-induced heart failure","volume":"10","author":"Uchihashi","year":"2017","journal-title":"Circ. Heart Fail."},{"issue":"7","key":"10.1016\/j.ejphar.2026.179309_bib35","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S2213-8587(24)00102-5","article-title":"Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis","volume":"12","author":"Usman","year":"2024","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"12","key":"10.1016\/j.ejphar.2026.179309_bib36","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.004953","article-title":"Increased cardiac uptake of ketone bodies and free fatty acids in human heart failure and hypertrophic left ventricular remodeling","volume":"11","author":"Voros","year":"2018","journal-title":"Circ. Heart Fail."},{"issue":"3","key":"10.1016\/j.ejphar.2026.179309_bib37","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jcmg.2022.11.012","article-title":"Prognostic value of RV abnormalities on CMR in patients with known or suspected cardiac sarcoidosis","volume":"16","author":"Wang","year":"2023","journal-title":"JACC, Cardiovasc. Imaging"},{"issue":"5\u20136","key":"10.1016\/j.ejphar.2026.179309_bib38","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3109\/10408449209146311","article-title":"Mechanisms and pathology of monocrotaline pulmonary toxicity","volume":"22","author":"Wilson","year":"1992","journal-title":"Crit. Rev. Toxicol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179309_bib39","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12933-022-01614-5","article-title":"Dapagliflozin reduces the vulnerability of rats with pulmonary arterial hypertension-induced right heart failure to ventricular arrhythmia by restoring calcium handling","volume":"21","author":"Wu","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"issue":"12","key":"10.1016\/j.ejphar.2026.179309_bib40","article-title":"Dapagliflozin protects against chronic heart failure in mice by inhibiting macrophage-mediated inflammation, independent of SGLT2","volume":"4","author":"Wu","year":"2023","journal-title":"Cell Rep. Med."},{"issue":"11","key":"10.1016\/j.ejphar.2026.179309_bib41","doi-asserted-by":"crossref","first-page":"9799","DOI":"10.21037\/jtd-2025-1363","article-title":"SCM-198 ameliorates pulmonary arterial hypertension by modulating gut microbiota in rats","volume":"17","author":"Xiong","year":"2025","journal-title":"J. Thorac. Dis."},{"issue":"5","key":"10.1016\/j.ejphar.2026.179309_bib42","article-title":"DNMT3A facilitates breast cancer progression via regulating ADAMTS8 mediated EGFR-MEK-ERK activation","volume":"20","author":"Yang","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2026.179309_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.797137","article-title":"ADAMTS8 promotes cardiac fibrosis partly through activating EGFR dependent pathway","volume":"9","author":"Zha","year":"2022","journal-title":"Front. Cardiovasc. Med."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926007910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926007910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:20:31Z","timestamp":1791562831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926007910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":43,"alternative-id":["S0014299926007910"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179309","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dapagliflozin ameliorates pulmonary arterial hypertension-induced right heart failure via ketone body metabolism and mitochondrial function enhancement","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179309","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"179309"}}